Showing codes J7402 (Mometasone furoate sinus implant, (sinuva), 10 micrograms) — J7608 (Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram)

J7402 - Mometasone sinus sinuva
Long description: Mometasone furoate sinus implant, (sinuva), 10 micrograms
Code added date: 20210401.
Code effective date: 20210401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7500 - Azathioprine oral 50mg
Long description: Azathioprine, oral, 50 mg
Code added date: 19880101.
Code effective date: 20000101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7501 - Azathioprine parenteral
Long description: Azathioprine, parenteral, 100 mg
Code added date: 19880101.
Code effective date: 20000101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7502 - Cyclosporine oral 100 mg
Long description: Cyclosporine, oral, 100 mg
Code added date: 20000101.
Code effective date: 20000101.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7503 - Tacrol envarsus ex rel oral
Long description: Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
Code added date: 20160101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7504 - Lymphocyte immune globulin
Long description: Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
Code added date: 19880101.
Code effective date: 20020101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7505 - Monoclonal antibodies
Long description: Muromonab-cd3, parenteral, 5 mg
Code added date: 19880101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7506 - Prednisone oral
Long description: Prednisone, oral, per 5 mg
Code added date: 19890101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7507 - Tacrolimus imme rel oral 1mg
Long description: Tacrolimus, immediate release, oral, 1 mg
Code added date: 19950101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7508 - Tacrol astagraf ex rel oral
Long description: Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
Code added date: 20140101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7509 - Methylprednisolone oral
Long description: Methylprednisolone oral, per 4 mg
Code added date: 19960101.
Code effective date: 20000101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7510 - Prednisolone oral per 5 mg
Long description: Prednisolone oral, per 5 mg
Code added date: 19960101.
Code effective date: 20000101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7511 - Antithymocyte globuln rabbit
Long description: Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
Code added date: 20020101.
Code effective date: 20020101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7512 - Prednisone ir or dr oral 1mg
Long description: Prednisone, immediate release or delayed release, oral, 1 mg
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7513 - Daclizumab, parenteral
Long description: Daclizumab, parenteral, 25 mg
Code added date: 19990101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7514 - Mycophenol (myhibbin) 100 mg
Long description: Mycophenolate mofetil (myhibbin), oral suspension, 100 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7515 - Cyclosporine oral 25 mg
Long description: Cyclosporine, oral, 25 mg
Code added date: 20000101.
Code effective date: 20000101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7516 - Inj, cyclosporine 250mg
Long description: Injection, cyclosporine, 250 mg
Code added date: 20000101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7517 - Mycophenolate mofetil oral
Long description: Mycophenolate mofetil, oral, 250 mg
Code added date: 20000101.
Code effective date: 20000101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7518 - Mycophenolic acid
Long description: Mycophenolic acid, oral, 180 mg
Code added date: 20050101.
Code effective date: 20050101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7519 - Inj. mycophenolate mofetil
Long description: Injection, mycophenolate mofetil, 10 mg
Code added date: 20231001.
Code effective date: 20231001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7520 - Sirolimus, oral
Long description: Sirolimus, oral, 1 mg
Code added date: 20010101.
Code effective date: 20010101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7525 - Tacrolimus injection
Long description: Tacrolimus, parenteral, 5 mg
Code added date: 20010101.
Code effective date: 20010101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7527 - Oral everolimus
Long description: Everolimus, oral, 0.25 mg
Code added date: 20130101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7599 - Immunosuppressive drug noc
Long description: Immunosuppressive drug, not otherwise classified
Code added date: 19960101.
Code effective date: 20000101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7601 - Ensifentrine inh 3 mg
Long description: Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7604 - Acetylcysteine comp unit
Long description: Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7605 - Arformoterol non-comp unit
Long description: Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7606 - Formoterol fumarate, inh
Long description: Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
Code added date: 20090101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7607 - Levalbuterol comp con
Long description: Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7608 - Acetylcysteine non-comp unit
Long description: Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
Code added date: 20000101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF